AG
Aberdeen Group plc disclosed a 8% stake in IMUX
Aberdeen Group plc reported owning 8% of Immunic, Inc. (IMUX) (1,090,427 shares) in a Schedule 13G filed Nov 2, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
Aberdeen Group plc reported owning 8% of Immunic, Inc. (IMUX) (1,090,427 shares) in a Schedule 13G filed Nov 2, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.